NASDAQ
No price data available for this timeframe.
Beam Therapeutics Inc. (BEAM) has a fcf yield of -13.13% as of Friday, May 29, 2026. This represents a 79.08% decrease compared to its 12-month average of -7.33%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.